đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study is designed to investigate the safety and causal prophylactic ef...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-09-15
Trial ID
NCT04072302
This study will assess efficacy, safety , tolerability and PK in uncomplica...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-03
Trial ID
NCT01753323
Treatments Being Tested
This was Cohort B2 of the Platform study (NCT05750628) to evaluate the effi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2024-01-23
Trial ID
NCT07235033
Treatments Being Tested
This study aims to confirm the efficacy, safety and tolerability of KLU156,...
Status
Completed
Location
Novartis Investigative Site
Start Date
2024-03-07
Trial ID
NCT05842954
The purpose of this study is to assess the effect of multiple doses of gana...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-03-09
Trial ID
NCT05236530
This study was designed to determine the most effective and tolerable dose ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-08-02
Trial ID
NCT03167242
Treatments Being Tested
This study assessed the effect of multiple doses of a moderate inducer of c...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-04-28
Trial ID
NCT05330273
Treatments Being Tested
The study will assess the effect of multiple doses of itraconazole, a stron...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-11-18
Trial ID
NCT05084651
Treatments Being Tested
This study aimed to determine the efficacy, safety and tolerability of the ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-02-16
Trial ID
NCT04546633